Edition:
United Kingdom

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

31.76USD
26 Jun 2019
Change (% chg)

-- (--)
Prev Close
$31.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,813
52-wk High
$32.98
52-wk Low
$11.68

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

Beta: --
Market Cap(Mil.): $849.48
Shares Outstanding(Mil.): 26.75
Dividend: --
Yield (%): --

Financials

  ODT.OQ Industry Sector
P/E (TTM): -- 32.55 37.22
EPS (TTM): -4.10 -- --
ROI: -69.36 12.53 12.18
ROE: -69.83 13.83 17.03

Earnings vs. Estimates